 Mumbai : Panacea Biotec said on March 3 it has signed an advance market agreement with the Government of India to manufacture Pandyflu, the firm's swine flu vaccine.
The company, which has set up a manufacturing unit in Punjab for the vaccine, will have an annual capacity of 45 million doses, it said in a statement. The firm also said it expects the vaccine to be available by April 2010 for emergency use, it added.
|
